SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-067012
Filing Date
2023-08-14
Accepted
2023-08-14 16:05:24
Documents
14
Period of Report
2023-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea183450-8k_optimizerx.htm   iXBRL 8-K 33045
2 PRESS RELEASE, DATED AUGUST 14, 2023 ea183450ex99-1_optimize.htm EX-99.1 120700
6 GRAPHIC ex99-1_001.jpg GRAPHIC 4361
  Complete submission text file 0001213900-23-067012.txt   347918

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE oprx-20230814.xsd EX-101.SCH 3021
4 XBRL LABEL FILE oprx-20230814_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE oprx-20230814_pre.xml EX-101.PRE 22363
8 EXTRACTED XBRL INSTANCE DOCUMENT ea183450-8k_optimizerx_htm.xml XML 3303
Mailing Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453
Business Address 260 CHARLES STREET SUITE 302 WALTHAM MA 02453 248-651-6558
OptimizeRx Corp (Filer) CIK: 0001448431 (see all company filings)

IRS No.: 261265381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38543 | Film No.: 231169795
SIC: 7389 Services-Business Services, NEC